Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
732.55 INR | -1.19% |
|
+1.98% | -59.46% |
10/06 | Orchid Pharma Limited, Q4 2025 Earnings Call, May 26, 2025 | |
06/06 | Orchid Pharma Says NCLT Orders Disposal Of Orchid Pharma-DBS Bank Dispute | RE |
Capitalization | 3.72TCr 43Cr 37Cr 34Cr 32Cr 59Cr 66Cr 416.64Cr 157.28Cr 1.74TCr 161.82Cr 158.47Cr 6.4TCr | P/E ratio 2025 |
39.5x | P/E ratio 2026 * | 33.8x |
---|---|---|---|---|---|
Enterprise value | 3.53TCr 41Cr 35Cr 33Cr 30Cr 56Cr 63Cr 395.65Cr 149.35Cr 1.65TCr 153.67Cr 150.48Cr 6.08TCr | EV / Sales 2025 |
4.26x | EV / Sales 2026 * | 2.43x |
Free-Float |
30.16% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Orchid Pharma Limited
More press releases
1 day | -1.19% | ||
1 week | +1.98% | ||
Current month | +2.55% | ||
1 month | +5.96% | ||
3 months | -5.59% | ||
6 months | -55.00% | ||
Current year | -59.46% |
1 week | 715 | ![]() | 758.8 |
1 month | 678 | ![]() | 768.75 |
Current year | 603.8 | ![]() | 1,997.4 |
1 year | 603.8 | ![]() | 1,997.4 |
3 years | 296.1 | ![]() | 1,997.4 |
5 years | 17.5 | ![]() | 2,654.25 |
10 years | 17.5 | ![]() | 2,654.25 |
Manager | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 57 | 31/03/2020 |
Director of Finance/CFO | - | 29/06/2020 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12/2023 |
Director | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 31/03/2020 | |
Manish Dhanuka
BRD | Director/Board Member | 57 | 31/03/2020 |
Mridul Dhanuka
BRD | Director/Board Member | 43 | 31/03/2020 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.19% | +1.98% | -37.05% | +143.29% | 43Cr | ||
+1.34% | -2.69% | -9.09% | +139.83% | 69TCr | ||
+0.44% | +4.33% | +5.33% | -6.04% | 39TCr | ||
-1.12% | -1.66% | +10.59% | +26.54% | 33TCr | ||
-2.22% | -5.55% | -53.26% | -1.90% | 29TCr | ||
+0.58% | +0.66% | -7.15% | -21.43% | 26TCr | ||
-1.12% | -4.09% | -2.94% | +12.40% | 22TCr | ||
-0.17% | -1.49% | -15.11% | -7.23% | 21TCr | ||
-1.91% | -4.08% | -35.65% | -13.41% | 20TCr | ||
-1.17% | -0.17% | -10.94% | +20.88% | 16TCr | ||
Average | -0.58% | -1.37% | -15.53% | +29.29% | 27.65TCr | |
Weighted average by Cap. | -0.41% | -1.66% | -11.08% | +35.86% |
2025 | 2026 * | |
---|---|---|
Net sales | 928.8Cr 11Cr 9.25Cr 8.62Cr 8.02Cr 15Cr 17Cr 104.15Cr 39Cr 435.47Cr 40Cr 40Cr 1.6TCr | 1.45TCr 17Cr 14Cr 13Cr 13Cr 23Cr 26Cr 162.39Cr 61Cr 678.97Cr 63Cr 62Cr 2.5TCr |
Net income | 96Cr 1.12Cr 95.84L 89.3L 83.08L 1.53Cr 1.71Cr 11Cr 4.07Cr 45Cr 4.19Cr 4.1Cr 165.79Cr | 131.8Cr 1.53Cr 1.31Cr 1.22Cr 1.14Cr 2.1Cr 2.34Cr 15Cr 5.58Cr 62Cr 5.74Cr 5.62Cr 227.15Cr |
Net Debt | -187.2Cr -2.17Cr -1.86Cr -1.74Cr -1.62Cr -2.98Cr -3.33Cr -21Cr -7.92Cr -88Cr -8.15Cr -7.98Cr -322.62Cr | -190.4Cr -2.21Cr -1.9Cr -1.77Cr -1.64Cr -3.03Cr -3.39Cr -21Cr -8.06Cr -89Cr -8.29Cr -8.12Cr -328.14Cr |
More financial data
* Estimated data
Employees
871
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
18/25/18 | 732.55 ₹ | -1.19% | 70,500 |
17/25/17 | 741.35 ₹ | -1.00% | 75,632 |
16/25/16 | 748.85 ₹ | +1.20% | 69,603 |
15/25/15 | 739.95 ₹ | +2.76% | 1,94,628 |
14/25/14 | 720.05 ₹ | +0.24% | 1,02,016 |
Delayed Quote NSE India S.E., July 18, 2025 at 05:19 pm IST
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
732.55INR
Average target price
1,000.67INR
Spread / Average Target
+36.60%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ORCHPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition